STARTRK2 Ignyta Clinical Trial is still recruiting!

ignyta clinical trial

Lacuna Loft believes strongly in helping young adult cancer patients have better access to clinical trials and studies since these young adults are grossly underrepresented.  Adolescent and young adult cancer patients haven’t experienced an increase in survival rates since the ’70s and researchers believe that clinical trial participation could help change this!  Clinical trials help find cures and we love sharing them with you.

Ignyta is running a trial and bringing molecular testing to the forefront of cancer cures.  From Ignyta:

We’re writing to share information about the STARTRK-2 clinical trial (sponsored by Ignyta) that is currently recruiting patients across the country who have solid tumors harboring NTRK, ROS1, or ALK fusions.  Fusions are a certain type of DNA defect that have been reported to be oncogenic, meaning they could be a cause of your cancer.  By performing molecular testing on a piece of your tumor tissue, it may determine if your cancer has one of these fusions.

Ignyta can provide no-cost molecular testing to see if you may qualify for the trial.  In most cases, this test can be performed on a tumor sample that was previously obtained via biopsy and stored, avoiding the need for a new biopsy.

Eligible patients enrolled into the trial will receive a new investigational drug called Entrectinib.  Entrectinib has shown preliminary antitumor activity in many different types of cancers.  Click here to learn more about a recent update from our Phase 1 study.

Please speak with your doctor to determine if molecular testing is right for you.  You may also contact Ignyta at 1.844.STARTRK or via email at STARTRKtrials@ignyta.com to learn more about the trial and to find a participating study center near you.

Interested in other studies?  Check out more information we’ve shared recently here.

Sibling Mindfulness Project

sibling mindfulness project

Coping with a brother’s or sister’s cancer treatment can be tough. Researchers from the University of North Texas and CanTeen, an Australian organization for young people living with cancer, are exploring whether using a smartphone-based mindfulness app can help. If you are between 15 and 25 years old and have a sibling who has been diagnosed with cancer in the past five years, you may be eligible to participate in our research study.

Researchers will provide participants with a mindfulness app, ACT companion, which you will use over the 8-week period of the study. Participants will be asked to complete brief questionnaires before, after the intervention, and at 2-month follow-up. With this study, the researchers are hoping to explore whether mindfulness as a therapy (delivered by a smartphone app) can be helpful for you and whether family relationship styles affect how well mindfulness works. The results will be used to better understand how siblings are impacted by their brother’s or sister’s cancer, as well as what works to help.

To learn more and contact us, please visit https://goo.gl/9CxivF

STARTRK2 Ignyta Clinical Trial!

Ignyta clinical trial

Lacuna Loft believes strongly in helping young adult cancer patients have better access to clinical trials and studies.  Young Adult cancer patients are often underrepresented in clinical trials which is one of the facts researchers point to when citing that adolescent and young adult cancer patients haven’t experienced an increase in survival rates since the 70s, unlike both the younger and older cancer patient populations.  Clinical trials help find cures and we love sharing them with you.

We’ve shared about lots of different studies recently.  Check them out here if you haven’t already!

Today we’re talking about a trial that Igynta is running.  From Ignyta:

We’re writing to share information about the STARTRK-2 clinical trial (sponsored by Ignyta) that is currently recruiting patients across the country who have solid tumors harboring NTRK, ROS1, or ALK fusions.  Fusions are a certain type of DNA defect that have been reported to be oncogenic, meaning they could be a cause of your cancer.  By performing molecular testing on a piece of your tumor tissue, it may determine if your cancer has one of these fusions.

Ignyta can provide no-cost molecular testing to see if you may qualify for the trial.  In most cases, this test can be performed on a tumor sample that was previously obtained via biopsy and stored, avoiding the need for a new biopsy.

Eligible patients enrolled into the trial will receive a new investigational drug called entrectinib.  Entrectinib has shown preliminary antitumor activity in many different types of cancers.  Click here to learn more about a recent update from our Phase 1 study.

Please speak with your doctor to determine if molecular testing is right for you.  You may also contact Ignyta at 1.844.STARTRK or via email at STARTRKtrials@ignyta.com to learn more about the trial and to find a participating study center near you.

Interested in other studies?  Check out more information we’ve shared recently here.

Research Study Recruiting Male Young Adult Cancer Survivors

young male cancer survivors fertility study

UC San Diego Moores Cancer Center in collaboration with Oregon State University College of Public Health and Human Sciences is conducting a Fertility and Parenthood After Cancer study.

The purpose of the study is to find out more about young cancer survivors’ reproductive health and concerns about fertility and parenthood now or in the future.  They are currently recruiting male cancer survivors (age 18-35) to complete an online questionnaire about fertility and reproductive concerns after cancer.

The survey is anonymous and eligible participants will receive a $20 gift card after completing the survey.

If you have any questions about the study or recruitment, please contact investigator Jessica Gorman at jessica.gorman@oregonstate.edu or principle investigator T. Mike Hsieh at t7hsieh@ucsd.edu.

You can find the web survey and study information online, here.

 

National Study Is Looking For Male Young Adult Cancer Survivors

young men cancer survivors study

Studies that focus on young adult cancer survivors are few and far between.  Today though, we’re announcing one focused on young adult men who have had cancer.  They are asking questions like “What is it like to have cancer as a young man?” and “How has cancer affected your intimate relationships?”

From the study information:

Young men who have had cancer are being asked to share how they feel about their intimate relationships before and after their cancer experience. We would like to talk to young men who live anywhere in Canada, are at least 19 years of age, and were diagnosed with cancer when aged 15-29 years. Both young men with and without partners are invited to participate in the study.”

To participate in the study or for more information, please contact:

Katherine Holloway
Faculty of Nursing, University of New Brunswick (Fredericton)
Telephone: 506-447-3077
Email: cancerresearch@unb.ca
Facebook: facebook.com/YoungMenCancerTreatmentandIntimacy/

Survey! Sexual Functioning of Lesbians and Breast Cancer Survivors

Lacuna Loft is helping to spread the word about a research study, currently going on through Widener University.

People who meet the following criteria may be eligible:
– 21 years of age or older
– Identify as a member of the lesbian community (Both lesbian women without a breast cancer history and lesbian survivors of breast cancer can participate. “Woman” and “Lesbian” are broadly defined).
– Have been diagnosed with breast cancer at any stage

You may complete the survey here.

TORRISI- IRB Application Update- flyer number 2-page-001

Research Study For Canadian Cancer Survivors

Canadian cancer survivors

Are you a Canadian cancer survivor? A team at Dalhousie University in Halifax, Nova Scotia is researching ‘return to work’ in cancer survivors in Canada.  Taking part in research is a valuable use of time…it helps further our understanding of how cancer affects lives and how we can all work together to make improvements.

If you meet the criteria listed below and are interested in taking part in the return to work study, contact Emily Drake at 902.292.3859 or at emily.drake@dal.ca for more information.

Advertisement_RTW_ver6